NAROPIN Side Effects

6992107-X | Suicidal Ideation
on Sep 10, 2010 Female patient from GERMANY , weighting 114.6 lb, was diagnosed with pain (What is pain?) and was treated with Naropin (View Usage). Patient experienced the following unwanted or unexpected effects: suicidal ideation. Naropin dosage: . During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), DOMPERIDON (View Domperidon Review and Domperidon Label ), OMEP (View Omep Review and Omep Label ).

6968610-5 | Bronchospasm, Circulatory Collapse, Grand Mal Convulsion, Ventricular Fibrillation
Patient was taking Naropin (View Usage). Patient had the following side effects: bronchospasm, circulatory collapse, grand mal convulsion, ventricular fibrillation on Aug 31, 2010 from NORWAY Additional patient health information: Female patient , 84 years of age, was diagnosed with bone pain and. Naropin dosage: . During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ).

6933745-X | Anaphylactic Reaction, Cardiac Arrest, Coma, Respiratory Arrest
Adverse event was reported on Aug 17, 2010 by a Female patient taking Naropin (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: CHINA , 60 years of age, After Naropin was administered, patient had the following side effects: anaphylactic reaction, cardiac arrest (What is cardiac arrest?), coma, respiratory arrest. Patient was hospitalized.

6915983-5 | Circulatory Collapse
on Aug 05, 2010 Female patient from RUSSIAN FEDERATION , 23 years of age, weighting 152.1 lb, was diagnosed with anaesthesia, prophylaxis and was treated with Naropin (View Usage). Patient experienced the following unwanted or unexpected effects: circulatory collapse. Naropin dosage: . During the same period patient was treated with NO SPA (6.0 In 200 Ml Of 0.9% Nacl Saline) (View No-spa Review and No-spa Label ), COCARBOXYLASE (View Cocarboxylase Review and Cocarboxylase Label ), PROMEDOL (View Promedol Review and Promedol Label ), PIRACETAM (5 Ml In 200 Ml Of 0.9% Nacl Saline) (View Piracetam Review and Piracetam Label ), ASCORBIC ACID BUFUS (View Ascorbic Acid Bufus Review and Ascorbic Acid Bufus Label ).


6817077-6 | Circulatory Collapse
on Jul 02, 2010 Female patient from RUSSIAN FEDERATION , 23 years of age, weighting 152.1 lb, was diagnosed with anaesthesia, prophylaxis and was treated with Naropin (View Usage). Patient had the following side effects: circulatory collapse. Naropin dosage: . During the same period patient was treated with NO SPA (6.0 In 200 Ml Of 0.9% Nacl Saline) (View No-spa Review and No-spa Label ), COCARBOXYLASE (View Cocarboxylase Review and Cocarboxylase Label ), PROMEDOL (View Promedol Review and Promedol Label ), PIRACETAM (5 Ml In 200 Ml Of 0.9% Nacl Saline) (View Piracetam Review and Piracetam Label ), ASCORBIC ACID BUFUS (View Ascorbic Acid Bufus Review and Ascorbic Acid Bufus Label ).

6814319-8 | Asthenia, Circulatory Collapse, Hypoaesthesia
Patient was taking Naropin (View Usage). After Naropin was administered, patient had the following side effects: asthenia, circulatory collapse, hypoaesthesia on Jun 29, 2010 from RUSSIAN FEDERATION Additional patient health information: Female patient , 23 years of age, was diagnosed with anaesthesia, prophylaxis and. Naropin dosage: . During the same period patient was treated with PROMEDOL (View Promedol Review and Promedol Label ), NO SPA (6.0 In 200 Ml Of 0.9% Nacl Saline) (View No-spa Review and No-spa Label ), PIRACETAM (5 Ml In 200 Ml Of 0.9% Nacl Saline) (View Piracetam Review and Piracetam Label ).

6790270-7 | Cardiac Arrest, Coma, Respiratory Arrest
Adverse event was reported on Jun 21, 2010 by a Female patient taking Naropin (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: CHINA , 60 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), coma, respiratory arrest. Patient was hospitalized.

6737787-9 | Logorrhoea, Phosphenes, Sinus Tachycardia
on May 20, 2010 Male patient from FRANCE , 24 years of age, was diagnosed with anaesthesia and was treated with Naropin (View Usage). Patient had the following side effects: logorrhoea, phosphenes, sinus tachycardia. Naropin dosage: Single Administration. During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ).

6655492-4 | Logorrhoea, Phosphenes, Tachycardia
on Mar 23, 2010 Male patient from FRANCE , 24 years of age, was diagnosed with anaesthesia and was treated with Naropin (View Usage). After Naropin was administered, patient had the following side effects: logorrhoea, phosphenes, tachycardia. Naropin dosage: Single Administration. During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ).

6636378-8 | Circulatory Collapse, Coma, Epilepsy, Overdose
Patient was taking Naropin (View Usage). Patient experienced the following unwanted or unexpected effects: circulatory collapse, coma, epilepsy (What is epilepsy?), overdose on Mar 12, 2010 from BELGIUM Additional patient health information: Female patient , 84 years of age, weighting 172.0 lb, was diagnosed with postoperative analgesia and. Naropin dosage: 4 Ml/h. During the same period patient was treated with SUFENTA (1 Ug/ml, 4 Ml/h) (View Sufenta Review and Sufenta Label ), ANTIHYPERTENSIVA (View Antihypertensiva Review and Antihypertensiva Label ).

6634242-1 | Circulatory Collapse, Epilepsy
Adverse event was reported on Mar 11, 2010 by a Female patient taking Naropin (View Usage) (Dosage: 4 Ml/h) was diagnosed with postoperative analgesia and. Location: BELGIUM , 84 years of age, weighting 172.0 lb, Patient had the following side effects: circulatory collapse, epilepsy (What is epilepsy?). During the same period patient was treated with SUFENTA (1 Ug/ml, 4 Ml/h) (View Sufenta Review and Sufenta Label ), ANTIHYPERTENSIVA (View Antihypertensiva Review and Antihypertensiva Label ).

6632402-7 | Circulatory Collapse, Epilepsy
on Mar 08, 2010 Female patient from BELGIUM , 84 years of age, weighting 172.0 lb, was diagnosed with postoperative analgesia and was treated with Naropin (View Usage). After Naropin was administered, patient had the following side effects: circulatory collapse, epilepsy (What is epilepsy?). Naropin dosage: 4 Ml/h. During the same period patient was treated with SUFENTA PRESERVATIVE FREE (1 Ug/ml, 4 Ml/h) (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), ANTIHYPERTENSIVA (View Antihypertensiva Review and Antihypertensiva Label ).

6619995-0 | Dysphonia, Dyspnoea, Headache, Hypersensitivity, Nausea, Pyrexia, Rash Pruritic, Somnolence
on Mar 01, 2010 Female patient from NETHERLANDS , 40 years of age, was diagnosed with allergy test and was treated with Naropin (View Usage). Patient experienced the following unwanted or unexpected effects: dysphonia, dyspnoea, headache (What is headache?), hypersensitivity, nausea (What is nausea?), pyrexia, rash pruritic, somnolence. Naropin dosage: 0,075-0,75 Mg. Patient was hospitalized.

6617520-1 | Paraplegia
Patient was taking Naropin (View Usage). Patient had the following side effects: paraplegia on Feb 25, 2010 from RUSSIAN FEDERATION Additional patient health information: Female patient , 20 years of age, was diagnosed with postoperative analgesia and. Naropin dosage: .

6594444-X | Gait Disturbance, Neuropathy Peripheral, Pain In Extremity
Adverse event was reported on Feb 15, 2010 by a Female patient taking Naropin (View Usage) (Dosage: Single Administration) was diagnosed with local anaesthesia and. Location: FRANCE , 54 years of age, After Naropin was administered, patient had the following side effects: gait disturbance, neuropathy peripheral, pain in extremity. During the same period patient was treated with CLONIDINE HCL (Single Administration) (View Clonidine Hcl Review and Clonidine Hcl Label ). Patient was hospitalized.

6573414-1 | Gait Disturbance, Neuropathy Peripheral, Pain In Extremity
on Jan 28, 2010 Female patient from FRANCE , 54 years of age, was diagnosed with local anaesthesia and was treated with Naropin (View Usage). Patient experienced the following unwanted or unexpected effects: gait disturbance, neuropathy peripheral, pain in extremity. Naropin dosage: Single Administration. During the same period patient was treated with CLONIDINE HCL (Single Administration) (View Clonidine Hcl Review and Clonidine Hcl Label ). Patient was hospitalized.

6567967-7 | Back Pain, Dysaesthesia, Hypoaesthesia, Muscular Weakness
on Jan 19, 2010 Female patient from DENMARK , weighting 136.7 lb, was diagnosed with anaesthesia and was treated with Naropin (View Usage). Patient had the following side effects: back pain (What is back pain?), dysaesthesia, hypoaesthesia, muscular weakness. Naropin dosage: 1 Mg/ml. During the same period patient was treated with SUFENTANIL UNK MAH (0.5mcg/ml) (View Sufentanil -unk Mah Review and Sufentanil -unk Mah Label ).

6517773-4 | Neuromuscular Block Prolonged
Patient was taking Naropin (View Usage). After Naropin was administered, patient had the following side effects: neuromuscular block prolonged on Dec 17, 2009 from FRANCE Additional patient health information: Female patient , weighting 132.3 lb, . Naropin dosage: 11 Ml And Continuous Infusion At A Rate Of 10 Ml Per Hour, I.e. A Total Of 44 Mg In 2 Hours 15 Minut. During the same period patient was treated with SUFENTANIL CITRATE (0.2 Ug/ml And Continuous Infusion At A Rate Of 10 Ml Per Hour) (View Sufentanil Citrate Review and Sufentanil Citrate Label ). Patient was hospitalized.

6514890-X | Cauda Equina Syndrome
Adverse event was reported on Dec 16, 2009 by a Female patient taking Naropin (View Usage) (Dosage: ) was diagnosed with anaesthesia, postoperative analgesia and. Location: GERMANY , weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: cauda equina syndrome. During the same period patient was treated with SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), CARBOSTESIN (View Carbostesin Review and Carbostesin Label ).

6499022-9 | Bradycardia, Cold Sweat, Dizziness, Dyspnoea, Electrocardiogram P Wave Abnormal, Epigastric Discomfort
on Dec 08, 2009 Male patient from GERMANY , 70 years of age, weighting 167.6 lb, was diagnosed with local anaesthesia and was treated with Naropin (View Usage). Patient had the following side effects: bradycardia, cold sweat, dizziness (What is dizziness?), dyspnoea, electrocardiogram p wave abnormal, epigastric discomfort. Naropin dosage: . During the same period patient was treated with XYLONEST (View Xylonest Review and Xylonest Label ).

6480501-5 | Acute Respiratory Distress Syndrome, Hypotension, Pulmonary Oedema
on Dec 04, 2009 Female patient from BELGIUM , 63 years of age, weighting 116.8 lb, was diagnosed with hypotension and was treated with Naropin (View Usage). After Naropin was administered, patient had the following side effects: acute respiratory distress syndrome, hypotension, pulmonary oedema. Naropin dosage: 14 Mg/h, 105 Mg. During the same period patient was treated with DAFALGAN (View Dafalgan Review and Dafalgan Label ), IBITAN (View Ibitan Review and Ibitan Label ), DOLZAM (View Dolzam Review and Dolzam Label ), CEFACIDAL (View Cefacidal Review and Cefacidal Label ), COZAAR (View Cozaar Review and Cozaar Label ).

6450580-X | Acute Respiratory Distress Syndrome, Hypotension, Pulmonary Oedema
Patient was taking Naropin (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, hypotension, pulmonary oedema on Nov 19, 2009 from BELGIUM Additional patient health information: Female patient , 63 years of age, . Naropin dosage: . During the same period patient was treated with DAFALGAN (View Dafalgan Review and Dafalgan Label ), IBITAN (View Ibitan Review and Ibitan Label ), DOLZAM (View Dolzam Review and Dolzam Label ), CEFACIDAL (View Cefacidal Review and Cefacidal Label ).

6420675-5 | Joint Swelling, Pain, Staphylococcal Bacteraemia, Staphylococcal Infection
Adverse event was reported on Oct 12, 2009 by a Male patient taking Naropin (View Usage) (Dosage: 9 Ml, Knee Injection) was diagnosed with osteoarthritis (What is osteoarthritis?) and. Location: UNITED STATES , 60 years of age, weighting 245.0 lb, Patient had the following side effects: joint swelling, pain (What is pain?), staphylococcal bacteraemia, staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with DEPO MEDROL (Ndc#0810341328) (View Depo-medrol Review and Depo-medrol Label ). Patient was hospitalized.

6406204-0 | Grand Mal Convulsion, Resuscitation
on Oct 02, 2009 Male patient from UNITED STATES , 53 years of age, weighting 194.0 lb, was diagnosed with nerve block and was treated with Naropin (View Usage). After Naropin was administered, patient had the following side effects: grand mal convulsion, resuscitation. Naropin dosage: 10 Ml. During the same period patient was treated with CARBOCAIN (10 Ml) (View Carbocain Review and Carbocain Label ), DEXAMETHASONE 4MG TAB (4 Mg) (View Dexamethasone 4mg Tab Review and Dexamethasone 4mg Tab Label ).

6406198-8 | Grand Mal Convulsion
on Oct 02, 2009 Female patient from UNITED STATES , 22 years of age, weighting 190.0 lb, was diagnosed with nerve block and was treated with Naropin (View Usage). Patient experienced the following unwanted or unexpected effects: grand mal convulsion. Naropin dosage: 10 Ml. During the same period patient was treated with CARBOCAIN (10 Ml) (View Carbocain Review and Carbocain Label ), DEXAMETHASONE 4MG TAB (4 Mg) (View Dexamethasone 4mg Tab Review and Dexamethasone 4mg Tab Label ). Patient was hospitalized.

6369554-2 | Joint Injury, Joint Range Of Motion Decreased, Musculoskeletal Pain
Patient was taking Naropin (View Usage). Patient had the following side effects: joint injury, joint range of motion decreased, musculoskeletal pain on Jul 14, 2009 from UNITED STATES Additional patient health information: Male patient , 48 years of age, was diagnosed with musculoskeletal pain and. Naropin dosage: Continuious Via Pump, Intra-articular. During the same period patient was treated with PAIN PUMP (View Pain Pump Review and Pain Pump Label ).

6369553-0 | Joint Injury, Joint Range Of Motion Decreased, Musculoskeletal Pain
Adverse event was reported on Jul 14, 2009 by a Female patient taking Naropin (View Usage) (Dosage: Continuous Via Pump, Intra-articular) was diagnosed with musculoskeletal pain and. Location: UNITED STATES , 45 years of age, After Naropin was administered, patient had the following side effects: joint injury, joint range of motion decreased, musculoskeletal pain. During the same period patient was treated with PAIN PUMP (View Pain Pump Review and Pain Pump Label ).

6368020-8 | Joint Injury, Musculoskeletal Disorder, Musculoskeletal Pain
on Sep 10, 2009 Female patient from UNITED STATES , 41 years of age, was diagnosed with musculoskeletal pain and was treated with Naropin (View Usage). Patient experienced the following unwanted or unexpected effects: joint injury, musculoskeletal disorder, musculoskeletal pain. Naropin dosage: . During the same period patient was treated with PAIN PUMP (View Pain Pump Review and Pain Pump Label ).

6357785-7 | Joint Injury, Musculoskeletal Discomfort, Musculoskeletal Disorder, Musculoskeletal Pain
on Jul 14, 2009 Male patient from UNITED STATES , 39 years of age, was diagnosed with musculoskeletal pain and was treated with Naropin (View Usage). Patient had the following side effects: joint injury, musculoskeletal discomfort, musculoskeletal disorder, musculoskeletal pain. Naropin dosage: Continuous Via Pump, Intra-articular. During the same period patient was treated with PAIN PUMP (View Pain Pump Review and Pain Pump Label ).

6357781-X | Joint Injury, Musculoskeletal Disorder, Musculoskeletal Pain
Patient was taking Naropin (View Usage). After Naropin was administered, patient had the following side effects: joint injury, musculoskeletal disorder, musculoskeletal pain on Jul 14, 2009 from UNITED STATES Additional patient health information: Male patient , 59 years of age, was diagnosed with musculoskeletal pain and. Naropin dosage: Continuous Via Pump, Intra-articular. During the same period patient was treated with PAIN PUMP (View Pain Pump Review and Pain Pump Label ).

6357779-1 | Joint Injury, Musculoskeletal Disorder, Musculoskeletal Pain
Adverse event was reported on Jul 14, 2009 by a Female patient taking Naropin (View Usage) (Dosage: Continuous Via Pump, Intra-articular) was diagnosed with musculoskeletal pain and. Location: UNITED STATES , 41 years of age, Patient experienced the following unwanted or unexpected effects: joint injury, musculoskeletal disorder, musculoskeletal pain. During the same period patient was treated with PAIN PUMP (View Pain Pump Review and Pain Pump Label ).

6348304-X | Infection, Pain, Swelling
on Aug 21, 2009 Male patient from UNITED STATES , 60 years of age, weighting 245.0 lb, was diagnosed with osteoarthritis (What is osteoarthritis?) and was treated with Naropin (View Usage). Patient had the following side effects: infection (What is infection?), pain (What is pain?), swelling. Naropin dosage: 9 Ml, Knee Injection. Patient was hospitalized.

6348303-8 | Infection, Pain, Swelling
on Aug 21, 2009 Male patient from UNITED STATES , 61 years of age, weighting 192.0 lb, was diagnosed with meniscus lesion, patellofemoral pain syndrome and was treated with Naropin (View Usage). After Naropin was administered, patient had the following side effects: infection (What is infection?), pain (What is pain?), swelling. Naropin dosage: 9 Ml, Knee Injection. Patient was hospitalized.

6348301-4 | Infection, Pain, Swelling
Patient was taking Naropin (View Usage). Patient experienced the following unwanted or unexpected effects: infection (What is infection?), pain (What is pain?), swelling on Aug 21, 2009 from UNITED STATES Additional patient health information: Male patient , 48 years of age, weighting 225.0 lb, was diagnosed with osteoarthritis (What is osteoarthritis?) and. Naropin dosage: 9 Ml, Knee Injection.

6306475-5 | Joint Injury, Joint Range Of Motion Decreased, Musculoskeletal Pain
Adverse event was reported on Jul 14, 2009 by a Female patient taking Naropin (View Usage) (Dosage: Continuous Via Pump, Intra-articular) was diagnosed with musculoskeletal pain and. Location: UNITED STATES , 35 years of age, Patient had the following side effects: joint injury, joint range of motion decreased, musculoskeletal pain. During the same period patient was treated with PAIN PUMP (View Pain Pump Review and Pain Pump Label ).

6292200-3 | Inadequate Analgesia
on Jul 30, 2009 Female patient from UNITED STATES , 26 years of age, was diagnosed with labour pain and was treated with Naropin (View Usage). After Naropin was administered, patient had the following side effects: inadequate analgesia. Naropin dosage: 6 Ml One Time Epid. During the same period patient was treated with LIDOCAINE 1.5% W/ EPINEPHRINE 1:200,000 (3ml) (View Lidocaine 1.5% W/ Epinephrine 1:200,000 Review and Lidocaine 1.5% W/ Epinephrine 1:200,000 Label ).

6279144-8 | Convulsion
on Jul 20, 2009 Female patient from UNITED STATES , 20 years of age, was diagnosed with labour pain and was treated with Naropin (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Naropin dosage: . During the same period patient was treated with PITOCIN (View Pitocin Review and Pitocin Label ).

6271979-0 | Retinal Artery Occlusion
Patient was taking Naropin (View Usage). Patient had the following side effects: retinal artery occlusion on Jul 08, 2009 from FRANCE Additional patient health information: Female patient , weighting 138.9 lb, was diagnosed with local anaesthesia, hypertension, depression (What is depression?) and. Naropin dosage: . During the same period patient was treated with PERINDOPRIL (View Perindopril Review and Perindopril Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), MIANSERINE (View Mianserine Review and Mianserine Label ).

6264208-5 | Anaesthetic Complication, Overdose, Partial Seizures
Adverse event was reported on Jul 06, 2009 by a Female patient taking Naropin (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: AUSTRALIA , 25 years of age, weighting 132.3 lb, After Naropin was administered, patient had the following side effects: anaesthetic complication, overdose, partial seizures. Patient was hospitalized.

6239872-7 | Chondrolysis, Joint Range Of Motion Decreased, Musculoskeletal Discomfort, Musculoskeletal Pain
on Jun 04, 2009 Female patient from UNITED STATES , 61 years of age, was diagnosed with musculoskeletal pain and was treated with Naropin (View Usage). Patient experienced the following unwanted or unexpected effects: chondrolysis, joint range of motion decreased, musculoskeletal discomfort, musculoskeletal pain. Naropin dosage: Continuous Via Pump, Intra-articular. During the same period patient was treated with I FLOW ON Q PAIN PUMP (Device) (View I-flow On-q Pain Pump Review and I-flow On-q Pain Pump Label ).

6198018-4 | Monoplegia
on May 15, 2009 Female patient from FRANCE , 24 years of age, was diagnosed with nerve block, postoperative care, prophylaxis of nausea and vomiting and was treated with Naropin (View Usage). Patient had the following side effects: monoplegia. Naropin dosage: . During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), SUFENTANIL (View Sufentanil Review and Sufentanil Label ), DROLEPTAN (View Droleptan Review and Droleptan Label ), SEVORANE (View Sevorane Review and Sevorane Label ).

6196358-6 | Axonal Neuropathy
Patient was taking Naropin (View Usage). After Naropin was administered, patient had the following side effects: axonal neuropathy on May 11, 2009 from FRANCE Additional patient health information: Male patient , 45 years of age, was diagnosed with nerve block and. Naropin dosage: .

6180838-3 | Agitation, Cardiac Arrest, Convulsion, Hallucination, Muscle Rigidity, Respiratory Arrest
Adverse event was reported on Apr 27, 2009 by a Male patient taking Naropin (View Usage) (Dosage: ) was diagnosed with local anaesthesia and. Location: FRANCE , 42 years of age, Patient experienced the following unwanted or unexpected effects: agitation, cardiac arrest (What is cardiac arrest?), convulsion, hallucination, muscle rigidity, respiratory arrest.

6179145-4 | Cardiac Arrest, Coma, Convulsion
on Apr 27, 2009 Female patient from FRANCE , 33 years of age, was diagnosed with analgesia and was treated with Naropin (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), coma, convulsion. Naropin dosage: .

6175961-3 | Bradycardia, Cardiac Arrest, Confusional State, Electrocardiogram Qt Prolonged
on Apr 27, 2009 Female patient from FRANCE , 90 years of age, weighting 110.2 lb, was diagnosed with femoral neck fracture, ventricular fibrillation, myocardial ischaemia, dementia (What is dementia?) and was treated with Naropin (View Usage). After Naropin was administered, patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?), confusional state, electrocardiogram qt prolonged. Naropin dosage: . During the same period patient was treated with SOTALEX (View Sotalex Review and Sotalex Label ), NITRODEX (View Nitrodex Review and Nitrodex Label ), VASTAREL (View Vastarel Review and Vastarel Label ), PRAXILENE (View Praxilene Review and Praxilene Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6171255-0 | Cardiac Arrest, Hypoproteinaemia, Overdose, Respiratory Arrest, Ventricular Fibrillation
Patient was taking Naropin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), hypoproteinaemia, overdose, respiratory arrest, ventricular fibrillation on Apr 27, 2009 from FRANCE Additional patient health information: Female patient , weighting 143.3 lb, was diagnosed with postoperative analgesia and. Naropin dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), SUFENTANIL (View Sufentanil Review and Sufentanil Label ), ETOMIDATE (View Etomidate Review and Etomidate Label ), NIMBEX (View Nimbex Review and Nimbex Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), TAHOR (View Tahor Review and Tahor Label ). Patient was hospitalized.

6171154-4 | Cardiac Arrest, Coma, Convulsion
Adverse event was reported on Apr 27, 2009 by a Female patient taking Naropin (View Usage) (Dosage: ) was diagnosed with analgesia and. Location: FRANCE , 33 years of age, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), coma, convulsion.

6139672-2 | Anxiety, Dysphagia, Hypoaesthesia Facial, Swollen Tongue, Vision Blurred
on Mar 24, 2009 Female patient from NETHERLANDS , 38 years of age, was diagnosed with anaesthesia and was treated with Naropin (View Usage). After Naropin was administered, patient had the following side effects: anxiety (What is anxiety?), dysphagia, hypoaesthesia facial, swollen tongue, vision blurred. Naropin dosage: .

6124386-5 | Convulsion
on Mar 18, 2009 Male patient from UNITED STATES , 24 years of age, was diagnosed with nerve block and was treated with Naropin (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Naropin dosage: 150mg X1 Perineural 1. Patient was hospitalized.

6115176-8 | Cauda Equina Syndrome
Patient was taking Naropin (View Usage). Patient had the following side effects: cauda equina syndrome on Mar 06, 2009 from JAPAN Additional patient health information: Male patient , 72 years of age, weighting 114.6 lb, was diagnosed with epidural anaesthesia and. Naropin dosage: . During the same period patient was treated with CARBOCAIN AMPUL (1.5 % 10 Ml X2) (View Carbocain Ampul Review and Carbocain Ampul Label ), MORPHINE HYDROCHLORIDE (View Morphine Hydrochloride Review and Morphine Hydrochloride Label ), DORMICUM (View Dormicum Review and Dormicum Label ). Patient was hospitalized.